Tuesday, April 01, 2008 11:32:25 AM
Friday February 29, 11:36 am ET
PAOLI, Pa.--(BUSINESS WIRE)--AMETEK Inc. (NYSE:AME - News) today announced that it has named Patrick J. McGeehan as Vice President and General Manager, Specialty Metal Products. Mr. McGeehan joins AMETEK from Hoeganaes Corporation, where he was Senior Vice President of Operations and Technology.
“We are very pleased to welcome Patrick to AMETEK,” commented Frank Hermance, AMETEK Chairman and Chief Executive Officer. “He brings extensive operating and general management experience to his new position and is expected to make important contributions to the continued growth and success of our specialty metal products business.”
Mr. McGeehan has an extensive background in metallurgy and specialty metals and significant manufacturing management experience. He spent 24 years with Hoeganaes, where he held a variety of positions, including Manager of Research & Development, Plant Manager, Vice President of Operations and Senior Vice President of Technology.
Prior to Hoeganaes, Mr. McGeehan held positions in metallurgical management at Phoenix Steel Corporation and was a Process Development Metallurgist at Westinghouse Electric Corporation. He has a Bachelor of Science and Master of Science degrees in Materials Engineering from Drexel University.
Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with 2007 sales of more than $2.1 billion. AMETEK’s Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion and New Products. AMETEK’s objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P MidCap 400 Index and the Russell 1000 Index.
Forward-looking Information
Statements in this news release relating to future events, such as AMETEK’s expected business and financial performance, are "forward-looking statements". Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include our ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; our ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK’s filings with the Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.
Contact:
AMETEK Inc.
William J. Burke, 610-889-5249
http://biz.yahoo.com/bw/080229/20080229005561.html?.v=1
Recent AME News
- AMETEK Announces Record First Quarter Results and Raises 2024 Guidance • PR Newswire (US) • 05/02/2024 10:55:00 AM
- AMETEK Announces First Quarter 2024 Earnings Call and Webcasted Investor Conference Call Information • PR Newswire (US) • 04/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:07:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:58:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:35:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:15:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:06:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:01:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 06:49:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:02:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:04:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 08:22:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:19:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:13:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:08:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 08:33:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 08:32:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/12/2024 09:50:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:02:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/09/2024 08:36:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 05:42:21 PM
- AMETEK Increases Quarterly Dividend • PR Newswire (US) • 02/09/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 04:08:51 PM
- AMETEK Announces Record Fourth Quarter and Full Year Results • PR Newswire (US) • 02/06/2024 11:55:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM